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The presence of 3-O-sulfated glucosamine residues in heparin or heparan sulfate plays a role
in binding to antithrombin III and HSV infection. In this study, tandemmass spectrometry was
used to differentiate between two heparin disaccharide isomers containing variable sulfate at
C6 in a common disaccharide and C3 in a more rare one. The dissociation patterns shown by
MS2 and MS3 were clearly distinguishable between the isomers, allowing their differentiation
and quantitation. Using this technique, we show that an octasaccharide with 11 sulfate groups
with high affinity for inflammatory chemokine CCL2 does not contain 3-O-sulfated
disaccharides. (J Am Soc Mass Spectrom 2009, 20, 652–657) © 2009 Published by Elsevier
Inc. on behalf of American Society for Mass SpectrometryHeparin and heparan sulfate are glycosamino-glycans (GAGs) involved in a wide array ofprotein binding interactions. These interactions
are implicated in a diverse group of biological processes
such as viral invasion [1, 2], cell growth [3, 4], blood
coagulation [5], and tumor metastasis [6–10]. Over a
hundred different heparin binding proteins have been
identified [11]. Initially, such protein interactions were
believed to be relatively nonspecific. However, this
perception has evolved to include selective protein
binding, as research demonstrates specific GAG struc-
tural motifs can drastically alter protein binding affinity
[8, 12, 13]. Despite the role of GAG structure in protein
binding, exploration of specific GAG structural motifs
governing protein binding remains greatly hampered
due to lack of rapid and definitive means to ascertain
GAG substitution patterns.
Heparin and heparan sulfate consist of a repeating
disaccharide subunit containing either glucuronic acid
or iduronic acid connected via a 1-4 linkage to glu-
cosamine. These GAGs possess significant structural
diversity due to sugar stereochemistry and sulfation or
acetylation at numerous positions within the repeating
disaccharide subunit. The glucuronic acid and iduronic
acid ringsmay display 2-O-sulfation, and the glucosamine
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doi:10.1016/j.jasms.2008.12.002ring may have 6-O-sulfation or the rare 3-O-sulfation.
Glucosamine may also have either sulfation or acetyla-
tion at the primary amine [8, 9]. Sulfation and acetyla-
tion alone yield 24 possible substitution patterns.
Despite the rarity of 3-O-sulfation, this modification
has been implicated in a number of biologically relevant
pathways. Heparin binding to the serine protease in-
hibitor antithrombin III (ATIII) causes inhibition of two
proteases, thrombin and factor Xa, involved in blood
clotting leading to an anticoagulant effect [14]. Binding
depends on a particular pentasaccharide sequence re-
sponsible for binding ATIII containing a 3-O-sulfated
glucosamine [15]. This 3-O-sulfate is a critical structural
component of the ATIII binding sequence as removal
results in a 1000-fold decrease in binding affinity [13].
HSV gD also binds a 3-O-sulfated sequence of heparan
sulfate enabling viral entry into host cells [2, 16].
Researchers have employed numerous different meth-
ods to elucidate GAG structure as well as the pertinent
GAG protein binding sequence. Methods include NMR,
but this technique is difficult to apply due to relatively
large material requirements [8]. Other methods include
chromatography to identify disaccharide components
[17, 18] and mass spectrometry combined with selective
enzymatic digestion and desulfation [19–21]. Mass
spectrometry is a particularly attractive method for
structural analysis of GAGs because of minimal sample
requirements and relatively fast data acquisition. In-
struments capable of collision-induced dissociation
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the potential to disassociate GAG structures enabling
identification of specific sulfation sites.
A class of proteins displaying GAG binding capacity
are chemokines, small secreted proteins involved in
numerous biological processes such as inflammation
and development [22]. Research demonstrates that
GAG/chemokine interaction can be required for proper
in vivo function [23, 24]. Our laboratory identified
selective chemokine ligand 2 (CCL2) binding of 11
sulfated heparin octasaccharide fragments [25]. This
finding provides an opportunity to evaluate the role of
3-O-sulfation in a new GAG/protein interaction using
mass spectrometry.
Herein, we report on the analysis of a known che-
mokine binding GAG octasaccharide [25], whose disac-
charide composition has been determined and probed
for 3-O-sulfation. Application of successive CID events
generates cross-ring dissociation separating the pri-
mary amine, the 3-position, and the 6-position of glu-
cosamine enabling definitive identification of the spe-
cific site of sulfation within a GAG disaccharide
subunit. This method was applied to an 11-sulfated
heparin octasaccharide obtained via hydrophobic trap-
ping of CCL2/heparin complex to evaluate the role of
3-O-sulfation in the CCL2/heparin interaction.
Experimental
Reagents and Instrumentation
Heparin octasaccharide library was purchased from
Dextra (Reading, UK). CarboPac PA1 ion-exchange
column was purchased from Dionex (Sunnyvale, CA).
High-pressure liquid chromatography (HPLC) grade
solvents were purchased from Fisher Scientific (Santa
Clara, CA). SAX HPLC was purchased from Waters
Corporation (Milford, MA). Heparin desalting was per-
formed using 1 kDa Dispo-Biodialyzers (The Nest
Group, Southborough, MA). Oasis HLB C18 column
was purchased from Waters Corporation. Heparinase I,
II, and III were purchased from Seikagaku Corporation
(East Falmouth, MA). I-S and I-P disaccharide stan-
dards were purchased from Sigma-Aldrich (St. Louis,
MO). Disaccharide stock solutions were prepared at a
concentrations of 2 mM on the basis of their absorbance
at 232 nm in 0.03 M HCl 232  5500 M-1 cm-1) [26].
Mass spectra for compositional analysis were obtained
by using an ESI source on an LTQ MS (ThermoFinnigan,
San Jose, CA). Disaccharides were sprayed at a concen-
tration of 20 pmol/L in a 1:1 MeOH/H2O solution
containing 10 mM NH4OH and 5 pmol/L I-P internal
standard. Samples were introduced by flow injection at
10 L/min in 1:1 MeOH/H2O using a syringe pump
(Harvard Apparatus, Holliston, MA). Spectra were ob-
tained in negative ion mode by using a spray voltage of
3.5 kV and a capillary temperature of 220 °C for all
experiments. For MS2 experiments, a 3 m/z isolation
width was used for precursor ion selection at m/z 191.4,and the ion was activated at 20% normalized collision
energy for 100 ms, and the qz value was maintained at
0.250. For MS3 experiments, a 3 Da isolation width
was used for precursor ion selection at m/z 168.5, and
the ion was activated at 22% normalized collision
energy for 100 ms. Each mass spectrum obtained con-
tains an average of 10 scans. Xcalibur, version 1.4
(ThermoFinnigan), was used for data acquisition and
processing.
Generation of 3-O-Sulfated Di- and
Tetra-Saccharides
A CHO cell line transduced with three copies of the
human 3-OST-3A cDNA [27] were grown to confluence
in 850 cm2 tissue culture roller bottles in Ham’s F-12
medium containing 50 U/mL penicillin, 50 g/mL
streptomycin, 2 mM glutamine, and 10% fetal bovine
serum. For cellular GAG extraction, cells were washed
once in PBS and subjected to exhaustive digestion with
Pronase (Sigma/Aldrich) in PBS at 37 °C for 24 h
followed by filtration through 0.22 micron cellulose
acetate low protein binding membrane, anion-exchange
chromatography with DEAE- sephacel (GE Health-
care, Chalfont St. Giles, UK) and ethanol precipitation
as previously described [27]. The GAG chains were
pelleted, washed with ice-cold 70% ethanol, re-pelleted,
and dried. The GAG preparations were reconstituted in
100 L HS digest buffer (40 mM ammonium acetate and
3.3 mM calcium acetate, pH 7) per roller bottle. Enzy-
matic depolymerization was carried out with 2 mU each
of heparin lyases I, II, and III per roller bottle and
digested for 16 h at 37 °C. To determine the retention
times for specific disaccharides, a small sample of the
digest was analyzed on a C18 reverse phase column
(0.46 cm  25 cm) (Grace Davison Discovery Sciences,
Deerfield, IL) connected to a LCQ classic quadrupole
ion trap mass spectrometer equipped with an ESI source
and a quaternary HPLC pump (Thermo-Finnigan). The
isocratic steps were: 100% buffer A (8 mM acetic acid, 5
mM dibutylamine) for 10 min; 17% buffer B (70%
methanol, 8 mM acetic acid, 5 mM DBA) for 15 min;
32% buffer B for 15 min; 40% buffer B for 15 min; 60%
buffer B for 15 min and 100% buffer B for 10 min. Eluted
species were monitored in negative ion mode with the
signal intensity optimized for D2S0, a representative
disaccharide (GAG nomenclature described by Law-
rence et al., 2008) [28]. The capillary temperature and
spray voltage were kept at 140 °C and 4.75 kV, respec-
tively. Peak assignments were based on several criteria
including retention time, mass, and ion adduction [27].
Preparative amounts of heparan sulfate digests were
loaded onto the column and the 3-O-sulfated species
were collected at the expected retention times from the
divert valve attached to the mass spectrometer. Purity
was checked by LC/MS using the same criteria previ-
ously mentioned and disaccharide yield approximated
by comparing extracted ion current for D2S3 and D2S9
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under the same conditions.
Preparation of 11-Sulfated Heparin Octasaccharide
Heparin octasaccharide containing 11 sulfates was
isolated from the heparin octasaccharide library by
using strong anion-exchange HPLC and a method
similar to that described previously [29]. Approxi-
mately 400 g of an octasaccharide library was in-
jected onto a CarboPac PA1 column and SAX HPLC
was performed at a flow rate of 1 mL/min using
Solvent A (30 mM ammonium acetate, pH 3.5) and
Solvent B (3 M NaCl, 30 mM ammonium acetate pH
3.5). A typical gradient consisted of: (1) 1–11 min, 0%
B, (2) 11–110 min, 0–100% B, and (3) 111–120 min, 0%
B. Chromatograms were recorded by monitoring the
UV absorbance at 232 nm. Fractions corresponding to
the 11-sulfated octasaccharide were collected, lyoph-
ilized and extensively desalted by dialysis against
water using 1 kDa Dispo-Biodialyzers.
Preparation of CCL2
The CCL2 protein was expressed, purified, and pro-
cessed as previously described [30]. Briefly, CCL2 was
expressed using a codon-optimized construct in TAP302
cells. Soluble CCL2was purified by ion-exchange chroma-
tography followed by reverse-phase high-performance
liquid chromatography (RP-HPLC). The N-terminal
methionine was removed by aminopeptidase, leaving
authentic human CCL2, which was then subjected to
re-purification by RP-HPLC.
CCL2 Affinity Enrichment of 11-Sulfated
Octasaccharide
Octasaccharide was enriched by incubating 40 M
CCL2 with 200 M 11-sulfate octasaccharide in 100 L
of 100 mMNH4OAc solution (pH 6.8). The solution was
applied to an Oasis solid-phase extraction (SPE) car-
tridge (Waters) that had been previously conditioned
using 1 mL of methanol and then 1 mL of H2O. The
solid-phase SPE cartridge was flushed three times, each
using 1 mL 200 mMNH4OAc solution (pH 6.8) and then
eluted by 1 mL 760 mM NH4OAc (pH 6.8). The three
washing fractions and the final elution faction were
collected and desalted by dialyzing against water using
a dialyzer with a molecular weight cutoff (MWCO) of
1 kDa.
Compositional Analysis of Affinity Purified
Heparin Octasaccharide
Complete enzymatic digestion of heparin octasaccha-
ride to constituent disaccharides was carried out with 5
g heparin in 20 L of 20 mM ammonium acetate
buffer, pH 7.5, 2 mM calcium acetate, and 0.001 uniteach of heparinase I, heparinase II, and heparinase III,
incubated at 37 °C for 16 h [20]. The reaction was
quenched, yielding a final solution containing 20
pmol/L heparin disaccharide, 1:1 MeOH/H2O, 5
pmol/L internal standard I-P, and 10 mM ammonium
hydroxide. Samples were then analyzed using a combi-
nation of MS2 at m/z 191.4 and MS3 at 168.5 on an LTQ
mass spectrometer.
Results and Discussion
Mass spectra were collected for both the D2S6 and the
D2S3 disaccharide. As expected for positional isomers,
the MS1 data for each of the disaccharides were virtu-
ally indistinguishable; in both cases the triply charged
ion at m/z 191.4, representing a molecular weight of
574.43 Da, was the principle ion detected (Supplemen-
tary Figure 1, which can be found in the electronic
version of this article). These ions were isolated and
studied utilizing tandem mass spectrometry via CID.
The MS2 data for the disaccharide isomers displayed
different dissociation patterns and are clearly distin-
guishable (Figure 1). The D2S6 CID spectra (Figure 1a)
was dominated by cross-ring cleavage yielding ion A at
m/z 218.0, and by a water loss ion at m/z 185.3 (Figure
1c) (dissociation nomenclature described by Domon
and Costello, 1988) [31]. Dissociation also resulted in the
formation of X, Y, and B ions. Ion X, at m/z 138.0, is
singly charged and results from a cross ring cleavage of
the glucosamine residue, while ions Y and B, at m/z
168.5 and m/z 127.0, respectively, are the glycosidic
bond cleavage ions. The D2S3 CID spectra (Figure 1d)
displayed greater diversity. The two major species
resulted again from loss of water at m/z 185.3 and a
HSO4 loss ion appearing at m/z 238.5. Additional abun-
dant ions included a singly charged HSO4 at m/z 97 and
ion B with a water loss at m/z 118.0. Trace amounts of
ion A at m/z 218.0 were also detected, as well as other
dissociation species annotated in Figure 1c.
While the MS2 data of the D2S6 and D2S3 disaccha-
rides display clear differences in dissociation, and thus
preliminary differentiation is possible, none of the ob-
served fragments correspond to a cross ring cleavage
separating the 6 and 3 positions of the glucosamine ring
enabling definitive identification of the 3-O-sulfation
site. It is most intriguing that one simple modification
of 3-O versus 6-O-sulfation results in such drastically
different spectra. This effect was also quite pronounced
in earlier investigations of disaccharides carrying C-3
modifications [32, 33]. Since both D2S3 and D2S6 pro-
duced the Y ion at m/z 168.5 in the MS2 data, corre-
sponding to the glucosamine ring containing the struc-
tural variation, this ion was isolated and subjected to
further dissociation in an MS3 experiment. Similar to
the MS2 data, the MS3 data displayed differing dissoci-
ation patterns. The MS3 data of the D2S6 disaccharide
(Figure 1b) revealed ion 0,2A at m/z 199.0 and ion 0,2X at
m/z 138.0 with high abundance. The parent ion with
water loss was also observed at m/z 159.5. Only trace
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detected. The MS3 of the D2S3 disaccharide (Figure 1e)
contained two major ions; the precursor ion with HSO4
loss at m/z 240.0 and the HSO4 ion at m/z 97.0. The less
abundant 0,3X ion appears at m/z 123.5. The 0,3X ion
corresponds to an ion containing an N-sulfate and a
3-O-sulfate, resulting from cross-ring cleavage separat-
ing the 0,3X ion from the 6-position of the glucosamine
ring.
The 0,3X ion permits definitive identification of the
Figure 1. (a) D2S6 MS2 data, (b) D2S6 MS3 d
observed in MS2 dissociation, (d) D2S3 MS2 dat
observed in MS3 dissociation.D2S3 sulfation pattern in the MS3 data, and validatesCID as a rapid, effective tool to identify 3-O-sulfation in
GAG disaccharide structures with minimal sample ma-
terial. Interestingly, the D2S3 disaccharide standard
also displayed a high abundance of HSO4 ions in
contrast to the D2S6 disaccharide standard, suggesting
the 3-O-sulfate is more labile than sulfates on other
positions when the species undergo CID. Previously,
our laboratory developed a quantitative method to
determine GAG disaccharide composition [20] includ-
ing all non-3-O-sulfated species. Identification of sev-
(c) cross ring and glycosidic cleavage pattern
D2S3 MS3 data, (f) cross ring cleavage patternata,
a, (e)eral diagnostic ions, such as m/z 238.5 in MS2 and m/z
656 MEISSEN ET AL. J Am Soc Mass Spectrom 2009, 20, 652–657240 in MS3, in D2S3 samples enables incorporation of
this 3-O-sulfated species into existing mass spectrome-
try methodology for GAG quantitative compositional
analysis [20].
This CID-based method was used to explore the
possible involvement of 3-O-sulfation in the heparin/
CCL2 interaction. A fraction of 11-sulfated heparin
octasaccharide, previously determined to bind to CCL2
[25], was obtained via strong anion exchange chroma-
tography and incubated with CCL2 protein. The protein
was bound to a hydrophobic trapping column, and an
11-sulfated heparin fraction enriched for CCL2 affinity
was eluted from the column. This enriched eluent, and a
control 11-sulfated heparin octasaccharide fraction, were
enzymatically digested down to disaccharide constituents
[29]. The sulfated disaccharide ion obtained atm/z 191.4 in
the MS1 data were subjected to two successive rounds of
CID to probe for the presence of 3-O-sulfation. The MS2
and MS3 data (Table 1) obtained from both reaction
mixtures were virtually identical to the MS2 and MS3 data
obtained from the D2S6 disaccharide standard (Figure 2)
asserting that the 3-sulfated disaccharide subunits pos-
sessed a D2S6 structure. The absence of numerous diag-
nostic ions observed in the D2S3 standard, such as m/z
238.5 in the MS2 data, m/z 240.0 in the MS3 data, and the
0,3X ion in the MS3 data, illustrate that the D2S3 structure
was not present. The D0S9 disaccharide is not a possibility
since all three sulfates reside in the reducing ring, and the
mass of the prominent glycosidic bond cleavage ion
clearly precludes this possibility. The D2H9 isomer is also
eliminated since themass of the A ion does not include the
extra sulfate. Clearly, neither of these two isomers is
present.
Several GAG/protein interactions depend on 3-O-
sulfation [2, 13, 15, 16]. In contrast, our exploration of
Table 1. Ions observed in the MS2 and MS3 data
MS2 spectra of D2S6
standard
MS3 spectra of D2S6
standard
m/z Ion Charge m/z Ion Charge
127.0 B 2 80.0 SO3 1
138.0 X 1 97.0 HSO4 1
168.5 Y  H 2 138.0 0,2X 1
185.3 Parent-H2O 3 159.5 (Y  H)-H2O 2
218.0 A 2 199.0 0,2A 1
MS2 spectra of D2S3
standard
MS3 spectra of D2S3
standard
m/z Ion Charge m/z Ion Charge
97.0 HSO4 1 97.0 HSO4 1
118.0 B-H2O 2 123.5
0,3X 2
168.5 Y  H 2 240.0 (Y  H)-HSO4 1
185.3 Parent-H2O 3
218.0 A 2
222.0 Z-HSO4-H 1
238.5 Parent-HSO4 2
255.0 B  H 1the heparin/CCL2 interaction, using mass spectrometry
combined with CID, did not reveal measurable levels of
3-O-sulfate containing species, suggesting that 3-O-
sulfation may not be involved in chemotactic GAG/
protein interactions. Subsequently, while 3-O-sulfation
may be crucial for certain interactions, its function
could be limited to specific GAG/protein complexes
instead of playing a more universal role in chemotaxis
or protein binding.
Conclusions
We have utilized a mass spectrometry method using
CID to create cross-ring cleavage events separating the
numerous potential sulfation positions within the dis-
accharide subunit structure. This method allows for
robust, rapid detection and identification of individual
3-O-sulfate containing heparin structures, such as D2S3,
within a heterogeneous disaccharide mixture via iden-
tification of specific diagnostic ions. Exploration of
GAG/protein interaction has been greatly hampered
due to lack of effective means to investigate GAG
Figure 2. Spectra of CCL2 affinity enriched 11-sulfated heparin
fraction showing same product ions as observed for the D2S6
isomer (a) MS2 data, (b) MS3 data.structure, and this tool presents a means to improve our
657J Am Soc Mass Spectrom 2009, 20, 652–657 3-O-SULFATED HEPARIN DISACCHARIDE ISOMERSunderstanding of the relationship between GAG struc-
ture and protein binding affinity for individual GAG/
protein interactions.
This method was used to probe the possible role of
3-O-sulfation in the CCL2/GAG interaction, from a
heparin library. An 11-sulfated heparin octasaccharide
enriched for CCL2 binding affinity did not reveal the
presence 3-O-sulfation at a detectable level, suggesting
3-O-sulfation is not a prominent factor governing
CCL2/GAG binding.
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